Kitman Labs is a renowned sports science and performance intelligence company founded in 2012. The firm has established a remarkable track record collaborating with top governing bodies, leagues, teams, and athletes across various elite sports organizations and universities, including the NFL, NBA, Premier League, MLS, and NCAA. Headquartered in Silicon Valley with offices in Dublin and Manchester, Kitman Labs is at the forefront of industry advancements. The company's flagship product, iP: The Intelligence Platform (iP), serves as an advanced operating system designed to optimize human performance, enhance overall health, reduce injury risk, and drive operational efficiencies. The platform encompasses software solutions for Performance Medicine, Performance Optimization, Coaching & Development, and League Operations. Notably, Kitman Labs boasts the largest network of elite and youth teams (2000+) and possesses the industry's most extensive dataset of talent, performance, and medical data for all stages of the athlete lifecycle.
The latest milestone for Kitman Labs involves a significant $52.00M Series C investment from key investors Guggenheim Investments and Transform Capital secured on 04 November 2021. Their slogan, "More than an AMS. Beyond an EMR," encapsulates their commitment to delivering comprehensive sports science and performance intelligence solutions. Operating at the intersection of AI, Analytics, IT, and Sports industries, Kitman Labs is poised for continued growth and influence in the sports technology sector.